Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Clegg

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
The Journal of Rheumatology|August 1, 1994
Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosusH J Williams, M J Egger, J Z Singer, et al.
The Journal of Rheumatology|September 1, 1991
Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue diseaseG S Alarcón, G V Williams, J Z Singer, et al.
Osteoarthritis and Cartilage|December 20, 2011
OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trialsR L Manno, C O Bingham, S Paternotte, et al.
The Journal of Rheumatology|October 23, 1997
A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial GroupM Tuttleman, S R Pillemer, B C Tilley, et al.
Genetic Epidemiology|July 22, 1998
Modelling the major histocompatibility complex susceptibility to RA using the MASC methodE Génin, M C Babron, M F McDermott, et al.
Annals of the Rheumatic Diseases|October 31, 2007
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitisJ C Davis, D M van der Heijde, J Braun, et al.
Arthritis and Rheumatism|March 4, 1998
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trialM L Barnett, J M Kremer, E W St Clair, et al.
Arthritis and Rheumatism|March 1, 1997
Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid ArthritisS R Pillemer, S E Fowler, B C Tilley, et al.
Annals of Internal Medicine|January 15, 1995
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial GroupB C Tilley, G S Alarcón, S P Heyse, et al.
The Journal of Rheumatology|March 7, 1998
Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseasesH J Williams, G S Alarcón, R Neuner, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
The Journal of Rheumatology|August 1, 1994
Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosusH J Williams, M J Egger, J Z Singer, et al.
The Journal of Rheumatology|September 1, 1991
Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue diseaseG S Alarcón, G V Williams, J Z Singer, et al.
Osteoarthritis and Cartilage|December 20, 2011
OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trialsR L Manno, C O Bingham, S Paternotte, et al.
The Journal of Rheumatology|October 23, 1997
A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial GroupM Tuttleman, S R Pillemer, B C Tilley, et al.
Genetic Epidemiology|July 22, 1998
Modelling the major histocompatibility complex susceptibility to RA using the MASC methodE Génin, M C Babron, M F McDermott, et al.
Annals of the Rheumatic Diseases|October 31, 2007
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitisJ C Davis, D M van der Heijde, J Braun, et al.
Arthritis and Rheumatism|March 4, 1998
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trialM L Barnett, J M Kremer, E W St Clair, et al.
Arthritis and Rheumatism|March 1, 1997
Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid ArthritisS R Pillemer, S E Fowler, B C Tilley, et al.
Annals of Internal Medicine|January 15, 1995
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial GroupB C Tilley, G S Alarcón, S P Heyse, et al.
The Journal of Rheumatology|March 7, 1998
Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseasesH J Williams, G S Alarcón, R Neuner, et al.
Pageof 9